ReviewMedicine2022
A review of cardiovascular benefits of SGLT2 inhibitors.
Yingxia Zhang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this papercites it
ReviewMedicine2022
Yingxia Zhang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.